Sign In
Buy OTLK
$0.81
-0.0038 (-0.467%)
At Close: Jun 03, 2026
ISELIN, N.J., Aug. 03, 2021 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company working to develop and launch the first FDA-approved ophthalmic formulation of
Hot Penny Stocks to Buy? 3 Stocks You Should Know About
02:45pm, Sunday, 02'nd May 2021
Penny stocks are ready for a new month; should you watch these 3? The post Hot Penny Stocks to Buy?
Outlook Therapeutics is bringing a treatment for retinal disease to the market at the right time
07:00am, Thursday, 29'th Apr 2021
There is something uniquely exciting about being the first company to bring a much-needed product to market. Outlook Therapeutics Inc (NASDAQ:OTLK) is hoping to become the first and only company to c
Why Bausch Health, Oncolytics Biotech, And More Are Moving Today
01:01pm, Wednesday, 17'th Feb 2021
iBio (NYSE: IBIO) shares are trading lower Wednesday after the company reported second-quarter earnings results. iBio's main area of business is plant-based protein expression technologies for vaccine
Notable Insider Buys Of The Past Week: Harley-Davidson, Texas Instruments And More
01:27pm, Saturday, 06'th Feb 2021
Insider buying can be an encouraging signal for potential investors, especially when markets face uncertainty. Some insiders have been taking advantage of secondary offerings recently.
Outlook Therapeutics Reports Financial Results for Fiscal Year 2020 and Provides Corporate Update
09:05am, Wednesday, 23'rd Dec 2020
MONMOUTH JUNCTION, N.J., Dec. 23, 2020 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a late clinical-stage biopharmaceutical company working to develop the first FDA-approved op
Outlook Therapeutics Announces Creation of Global Retina Advisory Council
08:05am, Thursday, 19'th Nov 2020
MONMOUTH JUNCTION, N.J., Nov. 19, 2020 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a late clinical-stage biopharmaceutical company working to develop the first FDA-approved opht
Virtual KOL Roundtable Recap: Outlook Therapeutics and Firas Rahhal, MD, Discussed wet AMD Treatment Landscape and ONS-5010/LYTENAVA™
09:05am, Wednesday, 11'th Nov 2020
MONMOUTH JUNCTION, N.J., Nov. 11, 2020 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a late clinical-stage biopharmaceutical company working to develop the first FDA-approved op
Outlook Therapeutics Secures $10 Million in Additional Working Capital
08:05am, Thursday, 05'th Nov 2020
MONMOUTH JUNCTION, N.J., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a late clinical-stage biopharmaceutical company working to develop the first FDA-approved op
Outlook Therapeutics Completes Patient Enrollment of Open-Label Safety Study for ONS-5010/LYTENAVA™ (bevacizumab-vikg)
08:35am, Tuesday, 03'rd Nov 2020
MONMOUTH JUNCTION, N.J., Nov. 03, 2020 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK), a late clinical-stage biopharmaceutical company working to develop the first FDA-approved op
UK coronavirus live: Nicola Sturgeon sets out Scotland's new lockdown tiers; Warrington agrees to enter tier 3
11:21am, Friday, 23'rd Oct 2020
Latest updates: England death rate rises for first time since April, ONS figures show; Warrington council reaches deal with government
Vaccines, vaping and the north-south divide: your Covid questions answered
11:54am, Thursday, 22'nd Oct 2020
You asked us about the science of the coronavirus, here are the answers
UK government borrowing rises to £36bn in September and inflation picks up – business live
08:19am, Wednesday, 21'st Oct 2020
Rolling coverage of the latest economic and financial news
UK public finances pushed into £36bn deficit as inflation rises
07:33am, Wednesday, 21'st Oct 2020
Covid government borrowing results in highest debt-to-GDP ratio since 1960
A third more deaths occurring at home than before Covid in England
01:44pm, Monday, 19'th Oct 2020
ONS data suggests people with life-threatening conditions still shying away from hospitals
